10-(Quinuclidin-3-ylmethyl)-10H-phenothiazine

Catalog No.: 
ACZFQG307
CAS No.: 
29216-28-2
Molecular Formula: 
C20H22N2S
Molecular Weight: 
322.48
10-(Quinuclidin-3-ylmethyl)-10H-phenothiazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$134.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name10-(Quinuclidin-3-ylmethyl)-10H-phenothiazine
IUPAC Name10-(quinuclidin-3-ylmethyl)-10H-phenothiazine
MDL No.MFCD01706743
Molecular FormulaC20H22N2S
Molecular Weight322.48
SMILESC12=CC=CC=C1N(CC3CN4CCC3CC4)C5=C(C=CC=C5)S2
InChI KeyHOKDBMAJZXIPGC-UHFFFAOYSA-N
SynonymMetaplexan | Phenothiazine, 10-(3-quinuclidinylmethyl)- | 10-(quinuclidin-3-ylmethyl)phenothiazine;Mequitazine | BDBM430669 | L000704 | MEQUITAZINE [WHO-DD] | (R)-10-(1-Azabicyclo[2.2.2]oct-3-ylmethyl)-10H-phenothiazine | 10H-Phenothiazine, 10-(1-azabicyc
CAS No.29216-28-2
PubChem CID4066

Safety Data

Pictogram
Toxic
Signal Word
Danger
Precautionary Statement(s)
P264-P270-P301+P310+P330-P405-P501

Synthetic Route by SureRoute

1. ACZFQG307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZFQG307 route product structure diagram
    ACZFQG30729216-28-2In Stock
Inquiry

2. ACZFQG307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZFQG307 route product structure diagram
    ACZFQG30729216-28-2In Stock
Inquiry

3. ACZFQG307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZFQG307 route product structure diagram
    ACZFQG30729216-28-2In Stock
Inquiry

Comments (0)